Access to Medicines

CHA

Tag: Access to Medicines

MSF to governments negotiating at WTO: get it right and adopt the real TRIPS Waiver

To effectively increase people’s access to all COVID medical tools, governments must return to TRIPS Waiver proposed over 20 months ago At the World Trade Organization (WTO) General Council Meeting (7 June) and the 12th WTO Ministerial Conference (12 –...

Read more

MSF responds to new WHO guidance recommending vastly shorter, improved and better-tolerated treatment for multi drug-resistant TB

Geneva, 3rd May, 2022 - Médecins Sans Frontières/Doctors Without Borders (MSF) are pleased that, having shared the results of TB PRACTECAL, our clinical trial that found a new, safer and more effective six-month oral treatment regimen for multi drug-resistant tuberculosis (MDR-TB), the World...

Read more

COVID-19: MSF urges governments to reject the draft COVID-19 text at WTO that would set a negative precedent

Draft text is NOT the intellectual property Waiver for COVID-19 medical tools people need Geneva – Almost one and a half years since India and South Africa first proposed a landmark intellectual property (IP) Waiver for COVID-19 medical tools at the World Trade...

Read more

MSF responds to latest WHO recommendation for a COVID-19 therapeutic, baricitinib

Geneva: With the World Health Organization (WHO) recommending baricitinib for the treatment of people with severe or critical COVID-19, Doctors Without Borders/Médecins Sans Frontières (MSF) calls on governments to take immediate steps to ensure that patent monopolies do not stand in...

Read more

Launch of public health partnership to tackle the silent epidemic of hepatitis C in low- and middle-income countries

The Drugs for Neglected Diseases initiative (DNDi), Médecins Sans Frontières (MSF), FIND, the global alliance for diagnostics, and the Treatment Action Group are joining forces to tackle a ‘silent’ public health injustice: the continuing disparities in access to diagnostics and...

Read more

MSF to wealthy countries: Don’t block and ruin the potential of a landmark waiver on monopolies during the pandemic

Geneva, Switzerland — Ahead of the next round of talks at the World Trade Organization (WTO) to discuss a proposal by South Africa and India to waive monopolies on COVID-19 medical tools during the pandemic, Médecins Sans Frontières/Doctors Without Borders...

Read more

Access to medicines: Will history repeat itself?

Rebutting pharma’s rejection of a global COVID-19 IP waiver By Felipe Carvalho, Yuanqiong Hu, Leena Menghaney In response to the COVID-19 “TRIPS waiver” proposal submitted by South Africa and India for a temporary waiver from certain pharmaceutical intellectual property (IP) obligations at...

Read more

Lebanon: Overlapping crises in Lebanon increase needs and worsen access to care

Since late 2019, Lebanon has been grappling with its worst economic crisis in decades, social unrest and political turmoil. On top of that, and following the arrival of the COVID-19 pandemic at the start of 2020, a major explosion tore through the capital, Beirut, in...

Read more

MSF: Governments must demand pharma make all COVID-19 vaccine licensing deals public

Terms of a deal disclosed show that we cannot rely on pharma’s goodwill to do the right thing, even in a pandemic. Geneva, 11 November 2020 – After the worrying terms of a deal struck between pharmaceutical corporation AstraZeneca and...

Read more

Access to Medicines: In landmark move, India and South Africa propose no patents on COVID-19 medicines, tools during pandemic

Governments make request to WTO for intellectual property waiver for all countries until herd immunity reached Geneva - In a landmark move, India and South Africa on 2 October asked the World Trade Organization (WTO) to allow all countries to...

Read more

Tuberculosis: Policies should ‘help facilitate access to life saving treatment not create barriers.’

Stobdan Kalon is a medical doctor working with Medecins Sans Frontieres/Doctors Without Borders (MSF). His experience spans from managing infectious diseases, interventions in Drug Resistant-Tuberculosis (DR-TB), hepatitis and HIV. As a doctor, I am elated that the World Health Organization...

Read more

Tuberculosis: MSF welcomes WHO revision in TB guidelines and urges greater access and affordability in India to new regimen

New Delhi, India: Doctors Without Borders/Medecins Sans Frontieres (MSF) has welcomed the revision made by the World Health Organisation (WHO) to its tuberculosis (TB) guidelines, allowing for safe use of a treatment regimen including both bedaquiline and delamanid for drug-resistant...

Read more
Show Buttons
Share On Facebook
Share On Twitter
Share On Linkedin
Contact us
Hide Buttons